Back to Search Start Over

TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.

Authors :
Du HY
Pumbo E
Ivanovich J
An P
Maziarz RT
Reiss UM
Chirnomas D
Shimamura A
Vlachos A
Lipton JM
Goyal RK
Goldman F
Wilson DB
Mason PJ
Bessler M
Source :
Blood [Blood] 2009 Jan 08; Vol. 113 (2), pp. 309-16. Date of Electronic Publication: 2008 Oct 17.
Publication Year :
2009

Abstract

Dyskeratosis congenita (DC) is a rare inherited form of bone marrow failure (BMF) caused by mutations in telomere maintaining genes including TERC and TERT. Here we studied the prevalence of TERC and TERT gene mutations and of telomere shortening in an unselected population of patients with BMF at our medical center and in a selected group of patients referred from outside institutions. Less than 5% of patients with BMF had pathogenic mutations in TERC or TERT. In patients with BMF, pathogenic TERC or TERT gene mutations were invariably associated with marked telomere shortening (<< 1st percentile) in peripheral blood mononuclear cells (PBMCs). In asymptomatic family members, however, telomere length was not a reliable predictor for the presence or absence of a TERC or TERT gene mutation. Telomere shortening was not pathognomonic of DC, as approximately 30% of patients with BMF due to other causes had PBMC telomere lengths at the 1st percentile or lower. We conclude that in the setting of BMF, measurement of telomere length is a sensitive but nonspecific screening method for DC. In the absence of BMF, telomere length measurements should be interpreted with caution.

Details

Language :
English
ISSN :
1528-0020
Volume :
113
Issue :
2
Database :
MEDLINE
Journal :
Blood
Publication Type :
Academic Journal
Accession number :
18931339
Full Text :
https://doi.org/10.1182/blood-2008-07-166421